Actively Recruiting
SHame prOpensity in bOrderline Personality Disorder
Led by University Hospital, Montpellier · Updated on 2025-09-30
688
Participants Needed
1
Research Sites
571 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Montpellier
Lead Sponsor
I
INSERM 1061, " Neuropsychiatry: epidemiological and clinical research", Montpellier
Collaborating Sponsor
AI-Summary
What this Trial Is About
Borderline Personality Disorder (BPD) is a common psychiatric disorder occurring in 2 to 6% of the population. 70% of patients with BPD do at least one Suicide Attempt (SA) in their lives. It makes BPD the most related to SA condition. Negative interpersonal events are among the main stressor inducing a SA. Patients with BPD are characterized by emotional dysregulation, impulsivity (repeated parasuicidal and suicidal behaviors), and instability in interpersonal relationships. The feeling of shame related to this psychiatric disorder could be one of the causes of the high SA rate. In this study, patients with BPD will be follow-up during 5 years. The main objective is to study the propensity to feel shame as a predictor of SA. This include: * Study of shame propensity as a predictive factor of suicidal behavior - Identify homogeneous subgroups of patients with BPD based on SA, and overall functioning. * Identify biological markers predicting SA * Identify predictive and protective treatments (pharmacological and psychotherapeutic) for SA
CONDITIONS
Official Title
SHame prOpensity in bOrderline Personality Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be 18 years of age or older
- Have a clinical diagnosis of Borderline Personality Disorder confirmed by SCID II
- Have signed the informed consent form
- Be able to understand the nature, purpose, and methods of the study
- Be able to understand and complete clinical evaluations
You will not qualify if you...
- Being deprived of liberty by judicial or administrative decision
- Being under legal guardianship or protected by law
- Currently in an exclusion period due to participation in another study
- Not affiliated with a social security scheme
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital of Montpellier
Montpellier, Hérault, France, 34295
Actively Recruiting
Research Team
D
Déborah DUCASSE, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here